ArticleThe British journal of cardiology2026

Ipilimumab/nivolumab-induced severe triple M syndrome in a patient with metastatic renal cancer.

Oghenevwede Okuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.